Friday, April 09, 2010

Anadys Pharmaceuticals Upward Momentum Looks to Continue (ANDS)

Written on Wed, 04/07/2010 - 11:34

By Chip Brian

SmarTrend identified an Uptrend for Anadys Pharmaceuticals (NASDAQ:ANDS) on December 03, 2009 at $2.58. In approximately 4 months, Anadys Pharmaceuticals has returned 7.7% as of today's recent price of $2.78.
Anadys Pharmaceuticals is currently above its 50-day moving average of $2.20 and above its 200-day moving average of $2.23. Look for these moving averages to climb to confirm the company's upward momentum.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Anadys Pharmaceuticals shares.

Wednesday, April 07, 2010

ANDS

ANDS looks to make a run shortly with data being presented next week in Austria.

Here is the press release:

"Safety and Antiviral Activity of ANA598 in Combination with Pegylated Interferon alpha-2A Plus Ribavirin in Treatment-Naive Genotype 1 Chronic HCV Patients"; April 15, 2010.

Anadys will present preliminary antiviral response and safety results from its ongoing Phase II study of ANA598 in HCV patients, in which ANA598 is being dosed for 12 weeks in combination with pegylated interferon and ribavirin (SOC). For the group receiving ANA598 at 400 mg twice-daily (bid) plus SOC, antiviral response and safety data through eight weeks will be presented, which data further confirm the profile demonstrated for ANA598 at 200 mg bid. Antiviral response and safety data for the complete control group receiving placebo plus SOC will also be updated through eight weeks. Data through 12 weeks will be presented for the group that received ANA598 200 mg bid plus SOC.

Poster Presentation on ANA598 Preclinical Data:

"Enhanced In Vitro Antiviral Activity of ANA598 in Combination with Other Anti-HCV Agents Support Combination Treatment"; April 16, 2010.

Anadys will present preclinical data showing enhanced activity and suppression of resistance when ANA598 is combined in vitro with other anti-HCV agents.

The abstracts for both presentations can be accessed through the EASL website at www.easl.ch. Thanks Yahoo finance.


More on this later tonight after I do some reading.

Wednesday, March 31, 2010

Updated 101: The Market Trend is BULLISH

I was looking forward to having a drink with a LEGAL hound tomorrow. 4-1-89 was truly a great day.

"The Master's hand that fashioned you, will never make another, to take your place in heart or home, though we live for ages.

Time takes away the edge of grief, but memory turns back every leaf"---Tenneyson

Happy Birthday Hound.


coming: updates NVLT, ANDS, and ISIS.